NKX2-3 and marginal zone lymphoma: Overall, these data indicate that NKX2-3 is normally not expressed in mature B lymphocytes, but its aberrant expression is preferentially observed in a subset of patients with marginal-zone lymphomas (including SMZL and MALT lymphomas).